Related Experiment Video
Updated: Sep 29, 2026

Quantification of Atherosclerosis in Mice
Published on: June 12, 2019
Combined effects of cholesterol reduction and apolipoprotein A-I expression on atherosclerosis in LDL receptor
Masa-aki Kawashiri1, YuZhen Zhang, Ellen Puré
1Department of Medicine, University of Pennsylvania Medical Center, School of Medicine, 654 Biomedical Research Building II/III, 421 Curie Blvd., Philadelphia, PA 19104, USA.
Insights
Combining cholesterol reduction and apolipoprotein A-I (apoA-I) overexpression did not further reduce atherosclerosis in mice. Neither strategy alone nor in combination showed a greater effect than individual treatments on reducing atherosclerosis.
Area of Science:
- Cardiovascular Science
- Genetics
- Metabolic Disorders
Background:
- Reduction in LDL cholesterol and increase in HDL cholesterol are linked to decreased atherosclerosis.
- Apolipoprotein A-I (apoA-I) overexpression reduces atherosclerosis in animal models.
- The combined effects of cholesterol reduction and apoA-I overexpression on atherosclerosis are not well understood.
Purpose of the Study:
- To investigate if combined cholesterol reduction and apoA-I overexpression have additive or synergistic effects on reducing atherosclerosis.
- To compare the efficacy of combined therapy against individual therapies in a murine model.
Main Methods:
- Utilized somatic gene transfer to express LDL receptor (for cholesterol reduction) and apoA-I in LDL receptor-deficient mice on a Western diet.
- Quantified atherosclerosis using en face analysis of the aorta and cross-sectional analysis of the aortic root.
- Compared outcomes of combined gene expression, individual gene expression, and control groups.
Main Results:
- LDL receptor expression alone reduced aortic atherosclerosis by 45% and aortic root atherosclerosis by 44%.
- ApoA-I overexpression alone reduced aortic atherosclerosis by 42% and aortic root atherosclerosis by 44%.
- Combined LDL receptor and apoA-I expression resulted in higher apoA-I levels but did not yield greater atherosclerosis reduction than individual treatments.
Conclusions:
- In this short-term mouse model, simultaneous cholesterol reduction and apoA-I overexpression did not provide greater atherosclerosis reduction compared to either intervention alone.
- Higher apoA-I levels were observed with combined therapy, but this did not translate to enhanced anti-atherosclerotic effects.
Abstract:
Reduction of total and LDL cholesterol reduces atherosclerosis and clinical cardiovascular events. High density lipoprotein (HDL) cholesterol levels have a strong inverse association with atherosclerosis, and overexpression of apolipoprotein A-I (apoA-I), the major protein component of HDL, reduces atherosclerosis in hypercholesterolemic animals. However, little is known about the potential for additive or synergistic effects between cholesterol reduction and apoA-I overexpression on atherosclerosis. In the current study, we tested the hypothesis that significant reduction of plasma cholesterol combined with overexpression of apoA-I would reduce atherosclerosis to a greater extent than either one alone. We used somatic gene transfer of the LDL receptor (to induce cholesterol reduction) and apoA-I in LDL receptor deficient mice fed a Western type diet and compared the combination to expression of each gene alone and to controls. Atherosclerosis was quantitated using two independent methods, by en face analysis of the entire aorta and by cross-sectional analysis of the aortic root. Although the reduction of cholesterol was transient, expression of the LDL receptor alone significantly reduced atherosclerosis by 45% in the aorta and 44% in the aortic root compared with controls. Overexpression of human apoA-I alone reduced atherosclerosis by 42% in the aorta and 44% in the aortic root compared with controls. Co-expression of the LDL receptor with apoA-I resulted in significantly higher levels of apoA-I than expression of apoA-I alone. Although co-expression of the LDL receptor and apoA-I reduced atherosclerosis by 37% in the aorta and 32% in the aortic root compared with controls, the reduction in atherosclerosis was no different than that seen with expression of the LDL receptor alone or apoA-I alone. In summary, in this relatively short-term murine model, simultaneous reduction of cholesterol and expression of apoA-I was associated with higher levels of apoA-I than expression of apoA-I alone but did not result in greater reduction in atherosclerosis compared with either one alone.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cholesterol: Significance and Regulation
Considering cholesterol and...
Atherosclerosis I: Introduction
Lipids: Dietary Sources and Requirements
